Updated:
TT Capital Partners
TT Capital Partners is a Bloomington-based private equity firm founded by ex-Optum executives that invests in healthcare IT and services.
TT Capital Partners
TT Capital Partners launched in 2011 when Tom Tiller Jr. and Dawn Owens formalized a partnership rooted in senior executive tenures at UnitedHealth Group and Optum. The firm set up in Bloomington, Minnesota, where that operator network is densest. Founders brought budget authority and operating cadence from running multi-billion-dollar P&Ls inside managed-care organizations — a distinction that shaped how the firm evaluates targets and supports portfolio management teams post-close. TT Capital invests mainly in healthcare services and healthcare IT businesses generating between $5 million and $50 million in revenue. The firm structures both majority buyouts and minority growth recapitalizations, with typical equity checks estimated to range from $10 million to $40 million (per industry convention for this fund size). Named portfolio companies include Aspire Health, a palliative-care provider acquired by Anthem in 2018, and Quest Analytics, a provider-network management software business. Other known holdings cover pharmacy-benefit technology, revenue-cycle management, and specialized care-delivery platforms. A common thread is buying founder-led businesses where an ex-Optum operator in the TT Capital network can serve as a bridge between the entrepreneurial founder and institutional scale. Team size has not been publicly confirmed, and the firm does not disclose assets under management. TT Capital raised its debut fund in 2012 and has since executed multiple vintages from investors that include institutional allocators and family offices, per public record. Dawn Owens, formerly CEO of OptumHealth, runs operations as CEO and partner; Tom Tiller Jr., a former CEO of the broader Optum business, serves as managing partner. No charitable foundation or co-investment club is publicly associated with the firm. TT Capital's structural edge is the tight coupling between its investment committee and a network of former UnitedHealth Group operating executives. That network creates a repeatable diligence cycle around claims data, network contracting, and regulatory reimbursement — areas generalist funds often outsource to pricey consultants. For founder-owners in healthcare IT and services, the implied offer is a liquidity event plus a leadership bench that has already scaled businesses inside the payer complex.
General information
Firm type
Private Equity
Year founded
2011
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Bloomington
Corporate office
Bloomington, MN, United States
Principals
Tom G. Tiller Jr.
Managing Partner
Dawn Owens
CEO & Partner
Ryan Engle
Partner
Casey Carlgren
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at TT Capital Partners?
Dawn Owens and Tom Tiller Jr. lead the firm as CEO and managing partner, respectively. Ryan Engle and Casey Carlgren serve as partners and hold voting seats on the investment committee. All four principals held senior roles at UnitedHealth Group or Optum prior to founding TT Capital in 2011.
Which sectors does TT Capital Partners explicitly target?
TT Capital concentrates on two verticals within healthcare: healthcare IT, particularly software businesses that manage provider networks and claims analytics, and healthcare services, including alternate-site care delivery and pharmacy-benefit management. The firm typically avoids biotech, diagnostics, and device plays that fall outside its operator expertise.
Is TT Capital Partners a fund-of-funds or a direct investor?
TT Capital is a direct private equity investor. It structures both majority buyouts and minority growth-equity deals in lower-middle-market healthcare companies. The firm does not publicly market a fund-of-funds product or secondary vehicle.
How does TT Capital source proprietary deal flow?
Sourcing leverages the founding partners' operator network inside the managed-care ecosystem — former UnitedHealth Group and Optum division presidents, regional plan leaders, and provider-group executives. This network surfaces founder-owned companies where the owner is wrestling with a reimbursement or regulatory shift that the TT Capital team has already navigated inside a large payer organization.
What is TT Capital's known posture on co-investments alongside external GPs?
The firm has historically syndicated with other sector-focused funds when a deal exceeds its equity-target range, but co-investment rights with limited partners are not publicly disclosed. TT Capital has also held board seats alongside growth-stage healthcare funds on select portfolio companies, per public record.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: